LDLR and familial hyperaldosteronism: In the study group with 61 FH patients, mutations in LDLR, APOB, PCSK9 genes were analyzed by MLPA and Sanger sequencing, revealing pathological results in 23 cases, with a mutation detection rate of 37.7%.